ComboMATCH trial—a collaboration across NCI and NCTN groups—matches patients with combination therapy trials based on tumor biology June 02, 2023Vol.49 No.22By Jacquelyn Cobb
FreeIn the Archives Marcus Humphrey on the long road to diagnosis and successful treatment of lymphoma with CAR T-cell therapy June 02, 2023Vol.49 No.22
Conversation with The Cancer LetterFree Robert Winn tells us how he led VCU Massey to obtain Comprehensive designation May 31, 2023Vol.49 No.22By Paul Goldberg
Conversation with The Cancer LetterFree Richard Pazdur discusses root causes of cisplatin and carboplatin shortage and what can be done to alleviate it May 30, 2023Vol.49 No.22By Paul Goldberg
Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die May 26, 2023Vol.49 No.21By Paul Goldberg
Conversation with The Cancer Letter ASCO’s Julie Gralow: At least 100,000 (and up to 500,000) cancer patients affected by cisplatin, carboplatin shortage May 26, 2023Vol.49 No.21By Paul Goldberg
Cancer History ProjectConversation with The Cancer Letter Karnofsky winner Hagop Kantarjian: We changed the course of leukemias from mostly incurable to mostly curable May 26, 2023Vol.49 No.21By Jacquelyn Cobb
FreeObituary Fred Hutch stem cell biologist Beverly Torok-Storb dies at 75 May 26, 2023Vol.49 No.21By Diane Mapes and Sabrina Richards
Guest Editorial Lessons in remote learning from NASDC—an educational program forced online by COVID-19 May 26, 2023Vol.49 No.21By Cauleen S. Noël, Miryam Yusufov and Ushma S. Neill
FreeIn the Archives George Santos and his contributions to the science of bone marrow transplantation May 26, 2023Vol.49 No.21
